When someone is very passionate about an industry or an activity, she is going to profit off of it if she builds a business. This is exactly what Whitney Wolfe has done with Bumble. She has worked very hard and put a lot of thought into the brand in order to make it something that is very unique and useful for women. One thing that she has wanted is to make sure that women have something that they can use without any of the hassles. This is one of the reasons that Bumble is such a hit with women.
Bumble has changed the way dating is done for women. Women who sign up for an account with Bumble have to initiate contact with a man they are interested in. Men are not able to initiate anything with a woman. This has given women a much better experience with online dating. For one thing, they are able to choose from the men that they are interested in. With other dating apps, they have a lot of messages in their inbox. Sometimes, it is quite overwhelming for them. This can cause them to not move forward with their desires to date.
Read more on pagesix.com
With all of the success that has come from Bumble, Whitney Wolfe has found herself in a position where she has to fight for her company. One thing that she is finding is that the corporate world can fight dirty when it comes to any industry. One thing that The Match Group has seen with Bumble is that it is a very successful company . Therefore, they want the success for themselves. This is one of the reasons that they are fighting very hard to buy the company. Whitney Wolfe is fighting to protect the company so that she will still have a platform for women.
Julie Zuckerberg is someone who is extremely well known in the talent acquisition industry. She is an incredibly talented recruiter who has worked with numerous larger companies and has placed numerous candidates in offices all across New York. Now, at the peak of her career, Zuckerberg has transitioned into a highly learned figure in the field of talent acquisition. Zuckerberg is currently at the position of Talent Acquisition Lead at Deutsche Bank, based out of New York City. She has been working at Deutsche Bank for quite a while now and has proven to be an precious asset to the company. Zuckerberg works alongside the higher up executives at the company and has helped them in numerous ways. She has helped the top level executives of the company with various decisions and is also one of the people who is responsible for negotiations that Deutsche Bank encountered.
At her current job, Zuckerberg leads an expert team of recruiters who have been trained and mentored by her. They help her with all her talent acquisition duties and perform all the on-site recruitments that take place in the company. Zuckerberg formulates a plan which the company can follow while undertaking their recruitment processes. In addition to conducting all the talent acquisition needs of the company, Zuckerberg is also the person who leads all of the training programs that the employees have to undertake. Since Julie Zuckerberg knows how to spot good ideals which can contribute to making good employees, she also conducts seminars and workshops, to inculcate these values in the employees of the company. They are trained in matters of leadership and teamwork and are then given opportunities for advancement based on how well they apply what they have learned.
Through the span of her career, Zuckerberg has worked with a broad array of companies, spreading across sectors and fields. She has collaborated with numerous business owners and people in business, helping them staff their organizations. Zuckerberg sees her job as a constant learning platform and consistently takes in whatever she can from the successful people that she meets. She has been mentored by some of the best in the field of talent acquisition, which has helped her rise to the position she is at today. This sheer love of the area and thirst for knowledge has taken her far, in a field that is rather male dominated.
Even though Zuckerberg started working in the field of talent acquisition straight out of university, the field was not what she always had in mind. In fact, she initially decided to take on a course in Philosophy, and then switched over to the law, to earn a law degree from the New York Law School. She then went on to take up a job at Hudson, where she played lawyers and paralegals in offices across the city.
Besides being focused on her work, Julie Zuckerberg is someone who loves art and culture and living in New York; she gets a healthy dose of it wherever she goes. She is known to actively takes part in numerous cultural festivals across the city.
Maverick Therapeutics, one of MPM’s Capital Portfolio Companies, has announced its partnership with Takeda Pharmaceutical Company Limited. The partnership will see both parties work together on a new improved form of T-Cell engagement therapies. Jeanmarie Guenot, Patrick Baeuerle and Luke Evnin, the founder of MPM, founded maverick Therapeutics, a startup biotechnology company, in 2016. Over the years, Maverick has been developing antibodies. The new partnership will enable Maverick to develop smaller and customizable T-Cell engagement therapies at https://www.linkedin.com/in/jeanmarie-guenot-4a140617. In addition, the $125 million partnership gives Takeda Company the right to purchase Maverick after 5 years.
About JeanMarie Guenot
JeanMarie Guenot is the CEO Amphivena Therapeutics, Inc., an innovative company that engages in the development of cancer therapies. For over two decades, Guenot has gained immense experience and knowledge in the pharmaceutical and biotechnology industry. Through her visionary and transformative leadership style, she has managed to enhance the company’s growth. JeanMarie is highly trained in physical and medicinal chemistry. She is an alumnus of the University of California and Wharton School at the University of Pennsylvania where she earned her PhD and MBA respectively. Her entrepreneurial career started at Atlas Venture where she founded her life science companies while she managed venture capital investments.
As a scientist, Guenot worked for Preclinical R&D at Hoffman-La Roche. Her boundless career saw her serve in different capacities for various companies, including private to public entities, pharmaceutical R&D, corporate and commercial corporations, venture capital, as well as project and alliance management. JeanMarie served as a vice president of PDL BioPharma before establishing SKS Ocular. This ophthalmic company focused on dry AMD besides releasing treatments and technologies for glaucoma, macular degeneration and ocular inflammation.
In her career, Guenot has entered into different partnerships with the objective of developing cancer drugs. In 2015, JeanMarie Guenot led the partnership between Amphivena and Janssen Biotech in the clinical investigation of undisclosed tumor antigen. Johnson and Johnson Innovation facilitated this process on amphivena.com. It aimed at advancing the development of therapies for hematologic malignancies. The success of this partnership was a major milestone for Amphivena. Guenot has specialized skills in oncology, neurology, autoimmunity and cardiovascular disorders and ophthalmic diseases.